{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:44:18Z","timestamp":1783565058912,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC1307600"],"award-info":[{"award-number":["2017YFC1307600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jare.2025.09.054","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:16:57Z","timestamp":1759303017000},"page":"965-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trial"],"prefix":"10.1016","volume":"84","author":[{"given":"Guozhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxiang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2467-534X","authenticated-orcid":false,"given":"Pengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9932","key":"10.1016\/j.jare.2025.09.054_b0005","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"22","key":"10.1016\/j.jare.2025.09.054_b0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"9891","key":"10.1016\/j.jare.2025.09.054_b0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jare.2025.09.054_b0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.jare.2025.09.054_b0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"J Am Med Assoc"},{"issue":"24","key":"10.1016\/j.jare.2025.09.054_b0035","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-021-03217-2","article-title":"Diabetes, hypertension, and cardiovascular disease development","volume":"20","author":"Yen","year":"2022","journal-title":"J Transl Med"},{"issue":"19","key":"10.1016\/j.jare.2025.09.054_b0045","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"33","key":"10.1016\/j.jare.2025.09.054_b0050","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"9689","key":"10.1016\/j.jare.2025.09.054_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.jare.2025.09.054_b0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2025.09.054_b0065","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","author":"Bi","year":"2024","journal-title":"N Engl J Med"},{"issue":"10380","key":"10.1016\/j.jare.2025.09.054_b0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"issue":"10339","key":"10.1016\/j.jare.2025.09.054_b0075","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jare.2025.09.054_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15092007","article-title":"Innovating new rural cooperative medical scheme (NCMS) for better patient satisfaction in rural China","volume":"15","author":"Gu","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"10.1016\/j.jare.2025.09.054_b0085","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ajh\/hpab038","article-title":"Rationale and design of a cluster randomized trial of a village doctor-led intervention on hypertension control in China","volume":"34","author":"Sun","year":"2021","journal-title":"Am J Hypertens"},{"issue":"17","key":"10.1016\/j.jare.2025.09.054_b0090","first-page":"e484","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12939-016-0505-7","article-title":"Development of village doctors in China: financial compensation and health system support","volume":"16","author":"Hu","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.jare.2025.09.054_b0100","unstructured":"2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16(3):182-241."},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: a world health organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"issue":"10112","key":"10.1016\/j.jare.2025.09.054_b0110","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)","volume":"390","author":"Lu","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jare.2025.09.054_b0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/pst.2293","article-title":"The stratified win statistics (win ratio, win odds, and net benefit)","volume":"22","author":"Dong","year":"2023","journal-title":"Pharm Stat"},{"issue":"14","key":"10.1016\/j.jare.2025.09.054_b0125","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/sim.8967","article-title":"Win odds: an adaptation of the win ratio to include ties","volume":"40","author":"Brunner","year":"2021","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/biom.12225","article-title":"An alternative approach to confidence interval estimation for the win ratio statistic","volume":"71","author":"Luo","year":"2014","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10543406.2023.2275759","article-title":"Adjusted win ratio using the inverse probability of treatment weighting","volume":"35","author":"Wang","year":"2025","journal-title":"J Biopharm Stat"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"2018","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"7597","key":"10.1016\/j.jare.2025.09.054_b0150","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.39136.682083.AE","article-title":"Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials","volume":"334","author":"Ferreira-Gonz\u00e1lez","year":"2007","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.jare.2025.09.054_b0155","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"18","key":"10.1016\/j.jare.2025.09.054_b0160","doi-asserted-by":"crossref","first-page":"e1484","DOI":"10.4244\/EIJ-D-19-00953","article-title":"Statistical methods for composite endpoints","volume":"16","author":"Hara","year":"2021","journal-title":"EuroIntervention"},{"issue":"7491","key":"10.1016\/j.jare.2025.09.054_b0165","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","article-title":"Validity of composite end points in clinical trials","volume":"330","author":"Montori","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12874-017-0462-x","article-title":"A systematic comparison of recurrent event models for application to composite endpoints","volume":"18","author":"Ozga","year":"2018","journal-title":"BMC Med Res Method"},{"issue":"46","key":"10.1016\/j.jare.2025.09.054_b0175","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1093\/eurheartj\/ehaa665","article-title":"The win ratio approach for composite endpoints: practical guidance based on previous experience","volume":"41","author":"Redfors","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.7895","article-title":"Graphing the win ratio and its components over time","volume":"38","author":"Finkelstein","year":"2019","journal-title":"Stat Med"},{"issue":"13","key":"10.1016\/j.jare.2025.09.054_b0185","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jacc.2023.06.047","article-title":"Generalized pairwise comparisons to assess treatment effects: JACC review topic of the week","volume":"82","author":"Verbeeck","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jare.2025.09.054_b0190","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacbts.2023.05.004","article-title":"Fallacies of using the win ratio in cardiovascular trials: challenges and solutions","volume":"8","author":"Ajufo","year":"2023","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"10.1016\/j.jare.2025.09.054_b0195","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s11606-023-08582-w","article-title":"Clinician\u2019s approach to advanced statistical methods: win ratios, restricted mean survival time, responder analyses, and standardized mean differences","volume":"39","author":"Lane","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"20","key":"10.1016\/j.jare.2025.09.054_b0200","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","article-title":"Transcatheter repair for patients with tricuspid regurgitation","volume":"388","author":"Sorajja","year":"2023","journal-title":"N Engl J Med"},{"issue":"10291","key":"10.1016\/j.jare.2025.09.054_b0205","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jare.2025.09.054_b0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jare.2025.09.054_b0215","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jare.2025.09.054_b0220","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1161\/CIR.0000000000001037","article-title":"Methodological standards for the design, implementation, and analysis of randomized trials in cardiac surgery: a scientific statement from the AMERICAN heart association","volume":"145","author":"Gaudino","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jare.2025.09.054_b0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2024.10510","article-title":"Dapagliflozin for critically ill patients with acute organ dysfunction: the defender randomized clinical trial","volume":"332","author":"Tavares","year":"2024","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jare.2025.09.054_b0235","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/biomet\/asw026","article-title":"On the win-ratio statistic in clinical trials with multiple types of event","volume":"103","author":"Oakes","year":"2016","journal-title":"Biometrika"},{"issue":"4","key":"10.1016\/j.jare.2025.09.054_b0240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2478\/jtim-2024-0014","article-title":"Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)","volume":"12","author":"Xiao","year":"2024","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.jare.2025.09.054_b0245","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.csbj.2021.03.003","article-title":"Association of risk factors with type 2 diabetes: a systematic review","volume":"19","author":"Ismail","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jare.2025.09.054_b0250","unstructured":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet (London, England). 2021;398(10304):957-80."},{"issue":"10199","key":"10.1016\/j.jare.2025.09.054_b0255","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","article-title":"The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults","volume":"394","author":"Geldsetzer","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.jare.2025.09.054_b0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.healthpol.2011.10.006","article-title":"Integrated care for chronic conditions: the contribution of the ICCC framework","volume":"105","author":"Nu\u00f1o","year":"2012","journal-title":"Health Policy"},{"issue":"8","key":"10.1016\/j.jare.2025.09.054_b0265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1911965","article-title":"A community-based intervention for managing hypertension in rural south Asia","volume":"382","author":"Jafar","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.118.12572","article-title":"Blood pressure control and the association with diabetes mellitus incidence: results from SPRINT randomized trial","volume":"75","author":"Roumie","year":"2020","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"10.1016\/j.jare.2025.09.054_b0275","article-title":"Role of diuretics, \u03b2 blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study","volume":"347","author":"Shen","year":"2013","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.jare.2025.09.054_b0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","article-title":"Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial","volume":"4","author":"Brown","year":"2016","journal-title":"Lancet Diabet Endocrinol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225007581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225007581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T20:08:49Z","timestamp":1780258129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225007581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S2090123225007581"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.09.054","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.09.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}